Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Design Therapeutics (DSGN) EBIT Margin (2020)

Design Therapeutics' EBIT Margin history spans 1 years, with the latest figure at 11700.0% for Q4 2020.

  • For Q4 2020, EBIT Margin changed N/A year-over-year to 11700.0%; the TTM value through Sep 2021 reached 86560.61%, changed N/A, while the annual FY2025 figure was 821.36%, 33381.0% down from the prior year.
  • EBIT Margin for Q4 2020 was 11700.0% at Design Therapeutics, up from 11915.0% in the prior quarter.
  • Across five years, EBIT Margin topped out at 438.73% in Q1 2020 and bottomed at 11915.0% in Q3 2020.